Essentially, Madam Chair, the reference is to the precautionary principle. So this gives us the provision in cases where the evidence might be suggestive but may not be definitive. It may still be evolving. We would have the authority to act. I think a good example, although obviously not under the auspices of this legislation, is what we've done with bisphenol A and polycarbonate baby bottles. There was enough of a suggestion that there could be a problem with the exposure to infants and newborns to BPA through baby bottles that we acted to prohibit the presence of that substance in those products.
I think that's probably the best example, the recent example of how that provision might materialize.